Aunins John G.

CIK 00016437561 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001643756

Recent Transactions

47 trades

Award
Seres Therapeutics, Inc.$MCRB
STOCK OPTION (RIGHT TO BUY)
2020-01-29+300,000→ 300,000 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
COMMON STOCK
2020-01-26+12,500→ 105,250 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
RESTRICTED STOCK UNITS
2020-01-26−12,500→ 0 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
COMMON STOCK
2019-01-26+7,500→ 92,750 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
RESTRICTED STOCK UNITS
2019-01-26−7,500→ 12,500 total
Award
Seres Therapeutics, Inc.$MCRB
STOCK OPTION (RIGHT TO BUY)
2019-01-25+60,000→ 60,000 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
COMMON STOCK
2018-12-19+10,000→ 85,250 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
RESTRICTED STOCK UNITS
2018-12-19−10,000→ 0 total
Sale
Seres Therapeutics, Inc.$MCRB
COMMON STOCK
2018-12-17$6.39/sh−14,282→ 75,250 total
Sale
Seres Therapeutics, Inc.$MCRB
COMMON STOCK
2018-11-15$8.26/sh−14,279→ 89,532 total
Sale
Seres Therapeutics, Inc.$MCRB
COMMON STOCK
2018-10-15$5.94/sh−14,279→ 103,811 total
Sale
Seres Therapeutics, Inc.$MCRB
COMMON STOCK
2018-09-17$7.27/sh−14,279→ 118,090 total
Sale
Seres Therapeutics, Inc.$MCRB
COMMON STOCK
2018-08-15$7.57/sh−14,279→ 132,369 total
Sale
Seres Therapeutics, Inc.$MCRB
COMMON STOCK
2018-07-15$8.10/sh−14,279→ 160,927 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
COMMON STOCK
2018-06-19+5,000→ 175,206 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
RESTRICTED STOCK UNITS
2018-06-19−5,000→ 10,000 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2018-06-15$8.57/sh−14,279→ 170,206 total
Sale
Seres Therapeutics, Inc.$MCRB
COMMON STOCK
2018-05-15$8.08/sh−14,279→ 146,648 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2018-04-25$7.58/sh−14,279→ 184,485 total
Award
Seres Therapeutics, Inc.$MCRB
STOCK OPTION (RIGHT TO BUY)
2018-01-30−40,000→ 40,000 total
Sale
Seres Therapeutics, Inc.$MCRB
COMMON STOCK
2018-01-26$11.02/sh−1,738→ 198,764 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
COMMON STOCK
2018-01-26+5,000→ 200,502 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
RESTRICTED STOCK UNITS
2018-01-26−5,000→ 20,000 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Common Stock
2017-12-19+5,000→ 61,060 total
Sale
Seres Therapeutics, Inc.$MCRB
COMMON STOCK
2017-12-19$10.14/sh−1,623→ 195,502 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
COMMON STOCK
2017-12-19+5,000→ 197,125 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2017-12-19$10.14/sh−1,623→ 59,437 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Restricted Stock Units
2017-12-19−5,000→ 15,000 total
Award
Seres Therapeutics, Inc.$MCRB
Restricted Stock Units
2017-06-19+20,000→ 20,000 total
Award
Seres Therapeutics, Inc.$MCRB
Stock Option (right to buy)
2017-01-26+50,000→ 50,000 total
Award
Seres Therapeutics, Inc.$MCRB
Restricted Stock Units
2017-01-26+25,000→ 25,000 total
Award
Seres Therapeutics, Inc.$MCRB
Stock Option (right to buy)
2016-09-19+30,000→ 30,000 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2016-08-29$10.87/sh−9,390→ 192,125 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2016-07-27$35.00/sh−9,250→ 201,515 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2016-07-25$34.18/sh−9,390→ 210,765 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Stock Option (right to buy)
2016-07-22−187,500→ 12,500 total
Exercise/Conversion
Seres Therapeutics, Inc.$MCRB
Common Stock
2016-07-22$0.48/sh+187,500→ 220,155 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2016-06-27$27.23/sh−9,390→ 32,655 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2016-05-31$30.57/sh−650→ 42,045 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2016-05-31$30.02/sh−13,365→ 42,695 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2016-04-25$31.94/sh−18,640→ 56,060 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2016-04-25$31.94/sh−18,640→ 56,060 total
Sale
Seres Therapeutics, Inc.$MCRB
Common Stock
2016-03-28$23.89/sh−9,390→ 74,700 total
Award
Seres Therapeutics, Inc.$MCRB
Stock Option (Right to Buy)
2016-02-01+69,000→ 69,000 total
Conversion
Seres Therapeutics, Inc.$MCRB
Series B Convertible Preferred Stock
2015-06-26−34,090→ 0 total
Conversion
Seres Therapeutics, Inc.$MCRB
Common Stock
2015-06-26+34,090→ 84,090 total
Award
Seres Therapeutics, Inc.$MCRB
Stock Option (right to buy)
2015-06-25+50,000→ 50,000 total

Companies

Seres Therapeutics, Inc.
CTO and EVP of Bioprocess Dev.
$MCRB

Recent Filings

Address

C/O SERES THERAPEUTICS, INC. 215 FIRST STREET

CAMBRIDGE, MA, 02142

View on SEC.gov